← Browse by Condition
Medical Condition

pet positive

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06096870 Phase 2
Recruiting

Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

Enrollment
65 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →